Searchable abstracts of presentations at key conferences in endocrinology

ea0016p554 | Obesity | ECE2008

25-Hydroxyvitamin D deficiency in premenopausal morbidly obese women

Galiana Pablo Abellan , Gomez Rosa Camara , del Olmo Garcia Maria Isabel , Marco Jose Luis Ponce , Torres Juan Francisco Merino , Alborg Vicente Campos , Selles Francisco Pinon

Background: Obesity has been associated with low levels of 25-hydroxyvitamin D (25(OH)D). This could be explained by a low dietary intake, reduced sun exposure or less biodisponibility because of its arrest in the fat mass. The main objective is to study the prevalence of 25(OH)D deficiency in premenopausal obese women.Methods: Aleatory sample of 100 morbidly obese patients. Selection criteria were: women, premenopausal, Caucasian. Patient with diabetes ...

ea0056p573 | Obesity | ECE2018

Effect of the rs12324955 polymorphism of the FTO gene in the intervention for the weight reduction in obese patients with the use of technological resources

Martin-Portugues Antonio Ballesteros , Cano Susana Rodrigo , Rodrigo Susana Tenes , Azorin Carolina Ortega , Marquez Eva Maria Asensio , Guerola Jose Vicente Sorli , Corella Piquer Dolores , Torres Juan Francisco Merino

Introduction: Obesity is a multifactorial disease in whose genetic factors are involved. The integration of this factors will allow to state personalized prevention strategies, where the constant contact with the patient will have a greater success for them to follow up recommendations. Continuous technological changes allow bigger accessibility to communication, having platforms with remote control.Objective: Assessing the effectiveness of an Intelligen...

ea0056p973 | Male Reproduction | ECE2018

Male hypogonadism due to 46, XX Testicular disorder of sex development

Font Mercedes Noval , Soler Guillermo Serra , Portilla Ana Jimenez , Barcelo Carlos Antich , Povedano Santiago Tofe , Ribas Elena Mena , Macazaga Vicente Pereg

Introduction: 46,XX testicular disorder of sex development (DSD) is a rare syndrome, which is characterized by a female karyotype in discordance with a male phenotype. It is presented with primary hypogonadism, gynecomastia and infertility. About 80–90% of 46,XX testicular DSD cases are positive for SRY gene. Appearance of external genitalia and masculinization are usually normal in 46,XX SRY-positive casesClinical case: A 41-year-old male came with...

ea0081ep663 | Pituitary and Neuroendocrinology | ECE2022

Hypothalamic syndrome secondary to systemic sarcoidosis

Vicente Gil Boix Jose , Soler Guillermo Serra , Font Mercedes Noval , Cubas Javier Bodoque , Raczkowski Meritxell Vin es , Sanmartin Sanchez Alicia , Tofe Povedano Santiago , Ribas Elena Mena , Marcet Mercedes Codina , Alcolea Josefina Olivares , Palou Francisca Caimari , Macazaga Vicente Pereg , ArguElles Imenez Inaki

Introduction: Sarcoidosis is a rare systemic disease where clusters of immune cells form granulomas in various organs of the body. Its prevalence ranges from 1-40 per 100,000 people in Europe. Neurological involvement of the disease occurs in 5-10% of cases, with the hypothalamus-pituitary gland being one of the most commonly affected structures.Clinical Case: A 36-year-old male with a history of hypertension, obesity, asthma and OSAS. He went to the eme...

ea0081oc6.2 | Oral Communications 6: Endocrine-Related Cancer | ECE2022

Translational evidence for splicing factor RBM22 as a novel prognostic biomarker and therapeutic target in prostate cancer

Saez-Martinez Prudencio , Jimenez-Vacas Juan M , Montero-Hidalgo Antonio J , Rosa-Herencia Ana D , Herrero-Aguayo Vicente , Leon-Gonzalez Antonio J , Sanchez-Sanchez Rafael , Gonzalez-Serrano Teresa , Gomez-Gomez Enrique , Gahete Manuel D , Luque Raul M

Prostate cancer (PCa) is one the leading causes of cancer-related deaths among men in developed countries. Therefore, identification of novel molecular and therapeutic approaches to tackle this pathology are urgently needed. In this scenario, our group has recently reported that elements of the cellular machinery controlling alternative splicing processes might be used as potential novel therapeutic tools against PCa and castration-resistant PCa (CRPC). In this context, RBM22 ...

ea0081p343 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Exposing the crosstalk between obesity and prostate cancer: miR-191-5p as personalized diagnostic and therapeutic tool

Porcel-Pastrana Francisco , Herrero-Aguayo Vicente , Saz-Martinez Prudencio , Jimanez-Vacas Juan M. , Carrasco-Valiente Julia , Lopez-Miranda Josa , Gomez-Gomez Enrique , Sarmento-Cabral Andra , Gahete Manuel D. , Luque Raul M.

Prostate cancer (PCa) is one of the most common causes of cancer-related deaths in men worldwide. Therefore, more specific non-invasive diagnostic biomarkers as well as novel therapeutic targets are urgently needed. As miRNAs have been proposed as promising elements for the identification of novel diagnostic and therapeutic tools for different pathologies, including cancer, we investigated the miRNA landscape in PCa patients and explored their putative diagnostic/therapeutic u...

ea0081p771 | Late-Breaking | ECE2022

SRSF6 (Serine/arginine-Rich Splicing Factor 6) is a novel factor regulating androgen receptor signalling in prostate cancer cells

Montero-Hidalgo Antonio J. , Manuel Jimenez-Vacas Juan , de la Salud De la Rosa-Herencia Ana , Herrero-Aguayo Vicente , Gomez-Gomez Enrique , Carlos Fuentes-Fayos Antonio , David Gahete-Ortiz Manuel , Miguel Luque-Huertas Raul

Prostate cancer (PCa) represents the most diagnosed tumour pathology in developed countries among men population. The main pharmacological approach to treat this pathology is based on the blockade of the androgen receptor signalling pathway, commonly known as androgen-deprivation therapy. However, some of the patients does no longer respond to this therapy, therefore developing castration-resistant prostate cancer (CRPC), the most aggressive phenotype of this pathology, which ...

ea0063oc12.3 | Endocrine Connections 2 | ECE2019

Neuronostatin and GPR107 system: a novel therapeutic circuit in prostate cancer

Saez-Martinez Prudencio , Jimenez-Vacas Juan M , Herrero-Aguayo Vicente , Leon-Gonzalez Antonio J , Gomez-Gomez Enrique , Montero-Hidalgo Antonio J , Requena-Tapia Maria J , Castano Justo P , Gahete Manuel D , Luque Raul M

Somatostatin (SST)-system is a pleiotropic hormonal system composed by several ligands/receptors that is involved in the regulation of multiple pathophysiological functions. Specifically, certain components of the SST-system are dysregulated in several endocrine-related cancer types compared to control tissues, wherein these alterations seem to influence their development/progression. However, the presence and functional role of neuronostatin (NST) and its putative G-protein c...

ea0063p224 | Diabetes, Obesity and Metabolism 1 | ECE2019

Prevalence of psychiatric comorbidities in diabetic patients who are candidates for therapy with SGLT2 inhibitors: clinical and metabolic characteristics

Larumbe Maria Concepcion Terroba , Soto Cristina Crespo , Mures Jose Maria Palacio , Sagrado Manuel Gonzalez , Vina Marta Ventosa , Lozano Silvia Pena , Martin Ainara Portela , Baranda Mar Calleja , Vicente Rosa Conde , Olmedo Luis Cuellar

Introduction: Depression, anxiety and eating disorders appear more frequently in patients with type 2 diabetes and are associated with worse metabolic control and higher risk of developing micro and macrovascular complications. The aim of this study was to determine the prevalence of psychiatric comorbidities in diabetic patients, candidates for therapy with SGLT2 inhibitors (SGLT2i) and to evaluate their clinical profile and degree of metabolic control before beginning the tr...

ea0049oc5.1 | Cardiovascular Endocrinology | ECE2017

Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes

Barros Eric , Ortiz David , Campino Carmen , Valdivia Carolina , Tapia-Castillo Alejandra , Lizama Jaime , Allende Fidel , Solari Sandra , Gonzalez Jose Vicente , Martinez-Aguayo Alejandro , Vecchiola Andrea , Repetto Gabriela , Aglony Marlene , Baudrand Rene , Salomon Carlos F , Fardella Carlos E , Carvajal Cristian

Arterial hypertension is a major health problem affecting 1.13 billion people worldwide, of which 10% could be due to endocrine pathologies related to the mineralocorticoid receptor (MR) (i.e. primary aldosteronism, 11β-hydroxysteroid dehydrogenase type 2 enzyme (HSD11B2) deficiency). The MR pathway is expressed mainly in placenta, kidney and colon epithelial cells. Current research highlights potential epigenetic regulatory mechanisms for the MR pathway. Here, specific m...